Dernières nouvelles pour Enka Insaat Ve Sanayi (OTC:EKIVF) Stock

Enka Insaat Ve Sanayi AS provides a full range of design, engineering, construction, and project management services in various sectors. It creates power plants, production facilities, transportation systems, and other construction projects. If needed, the company will engineer and fabricate structures for installation and modularization. Enka Insaat Ve Sanayi has four operating segments: construction contracts; rental, trade and manufacturing; and energy (the majority of total revenue). Additional revenue is generated from aftermarket support and services, and the company utilizes a mix of traditional engineering disciplines to produce results. The company derives the majority of its revenue from Turkey, but the company does operate in various European nations.

ENKA INSAAT VE SANAYI AS by Enka Insaat Ve Sanayi AS

Enka Insaat Ve Sanayi AS

On Monday, Aclaris Therapeutics, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRS#NASDAQ">ACRS</a>) entered into an exclusive license agreement with Biosion Inc for worldwide rights (excluding Greater China) to BSI-045B and BSI-502, a preclinical-stage, novel bispecific antibody directed against <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g42034751/aclaris-therapeutics-announces-exclusive-global-license-agreement-with-biosion-inc-adding-potentia" rel="noreferrer noopener">both TSLP and IL4R</a>.
In a completed Phase 2a, single-arm, proof-of-concept trial in the United States in 22 patients with moderate to severe atopic dermatitis, BSI-045B was observed to have a pharmacodynamic, safety, and efficacy profile.
BSI-045B is also being advanced in multiple Phase 2 studies in China by Biosion&#8217;s regional partner, Chia Tai Tianqing Pharmaceutical Group, Co., Ltd. (CTTQ), targeting severe asthma and chronic rhinosinusitis with nasal polyps, accelerating the potential to show proof-of-concept across additional indications.
Under the terms of the agreement, Biosion shall receive over&nbsp;$40 million&nbsp;cash payment as an upfront license fee and reimbursement for certain development costs &amp; drug product materials.
Biosion shall also receive 19.9% shares of Aclaris Therapeutics.
Additional regulatory and sales milestone payments exceed&nbsp;$900 million, with tiered low-to-mid single-digit royalty payments based on a percentage of <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42036056/biosion-announces-exclusive-global-license-agreement-with-aclaris-therapeutics-on-two-potential-fi" rel="noreferrer noopener">annual net sales</a>.
Leerink Partners upgraded Aclaris from Market Perform to Outperform, with a price target of $7, <a target="_blank" href="https://www.benzinga.com/quote/ACRS/analyst-ratings" rel="noreferrer noopener">up from $2</a>.
The analyst writes, &#8220;Following completion of their strategic review, we expect investor focus to shift to ACRS&#8217; newly strengthened immunology-focused pipeline.&#8221;
Leerink writes that these updates mark a fresh start for Aclaris Therapeutics, with a clear strategic direction and promising catalysts in the next 6-12 months. This progress could reduce risks for BSI-045B and significantly enhance its value.
The analyst has updated the model to include BSI-045 B&#8217;s potential in atopic dermatitis (AD), estimating around $1.3 billion in revenue by 2035 with a 35% probability of success. The analyst also anticipates multiple Phase 2 trial results from China in asthma and chronic rhinosinusitis with nasal polyps, which could provide more insight into BSI-045 B&#8217;s potential.
Additionally, Leerink expects further progress in de-risking the company&#8217;s pipeline in the first half of next year.
BTIG upgrades Aclaris Therapeutics from Neutral to Buy and announces a $8 price target.
Price Action: ACRS stock is up 55.60% at $4.88 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42063475/interactive-strength-shares-jumps-premarket-as-saudi-fitness-chain-adopts-clmbr-machines" target="_blank" rel="noreferrer noopener">Interactive Strength Shares Jump As Saudi Fitness Chain Adopts CLMBR Machines: Details</a></li>
</ul>

Analyst Color

Biotech

News

Upgrades

Health Care

Price Target

Contracts

Analyst Ratings

Movers

Trading Ideas

General

ACRS

Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments

<a href="https://www.benzinga.com/fintech-awards/livestream" title="https://www.benzinga.com/fintech-awards/livestream">https://www.benzinga.com/fintech-awards/livestream</a>

Events

Exclusives

GTN CEO, Americas Eric Krueger Says 90% Percent Of Trading Volume Is Into U.S. Market; As Long As U.S. Continues To Outperform, We Will See Massive Inflow Of Foreign Retail Investors

The retail investing landscape is changing as individuals are increasingly looking to take on more risk. Yoni Assia, co-founder and CEO of investing platform eToro, believes crypto is playing a big role in the <a href="https://www.benzinga.com/money/retail-investors-ve-institutional-investors">evolution of the retail investor</a>.
What To Know: Tuesday at the <a href="https://www.benzinga.com/fintech-awards?__hstc=28787939.5f6980ec6f37192ae95c332ee656a790.1732029557803.1732029557803.1732029557803.1&amp;__hssc=28787939.1.1732029557803&amp;__hsfp=3317113319">Benzinga Fintech Deal Day &amp; Awards</a>, Assia made the case that risk appetite is the biggest difference between older generations and retail investors today.
Older generations focused on dividend yields, the Baby Boomers started focusing on price-to-earnings multiples, Gen X began focusing more on growth, Millennials took it a step further and focused on tech stocks and now Gen Z is more focused on crypto and things like Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) becoming the currency of Mars, he said.
EToro started the year with just 2% of its customers trading crypto and now has more than 90% of customers involved with crypto in some capacity across its platform, Assia said.
Crypto is driving that bigger tolerance for risk due to its becoming a &#8220;generational asset class&#8221; and a &#8220;gateway trade&#8221; for a lot of individual investors. Many retail investors come to the platform to trade Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), for example, and then end up exploring other investment options, he said.
Many crypto investors have a higher appetite for risk and as crypto investors cross into traditional markets, retail traders are starting to make a bigger splash. The surge in retail investors in recent years has changed market dynamics, Assia explained.
Check This Out: <a href="https://www.benzinga.com/news/events/24/11/42071064/exclusive-anthony-pompliano-calls-for-us-to-buy-250b-bitcoin-on-day-1-of-trump-administration-protect-our-future-its-such-a-no-brainer">EXCLUSIVE: Anthony Pompliano Calls For US To Buy $250B Bitcoin On Day 1 Of Trump Administration: &#8216;Protect Our Future, It&#8217;s Such A No Brainer&#8217;</a>
The way investors get information has also changed. In the past, a lot of individuals would read investment reports and put a lot of time into researching a potential investment, but now traders are getting information very quickly from various news outlets and from other individual investors on social media platforms like Reddit and X. If they are reading research reports, they are likely using ChatGPT or another LLM to pull the key information, he added.
When talking about retail investors versus individual investors, you often hear the terms &#8220;dumb money&#8221; and &#8220;smart money,&#8221; but &#8220;I think that&#8217;s completely wrong,&#8221; Assia said: &#8220;We see it on our platform.&#8221;
eToro allows investors to see what other investors on the platform are doing and even copy their trades. Assia told the crowd at the Benzinga conference that there are 3,200 investors on the platform that are being copied by other traders. Most of those investors consistently generate double-digit returns and often outpace the S&amp;P 500. 
&#8220;These are like hedge-fund level returns of our top retail investors on the platform. I think this narrative is coming from the people who want to manage the retail&#8217;s money and don&#8217;t want them to manage their own money,&#8221; he said. 
The playing field is already in the process of being leveled and new AI tools are only going to help accelerate retail&#8217;s ability to see consistent success in the markets, Assia said. 
The <a href="https://www.benzinga.com/fintech-awards?__hstc=28787939.5f6980ec6f37192ae95c332ee656a790.1732029557803.1732029557803.1732029557803.1&amp;__hssc=28787939.1.1732029557803&amp;__hsfp=3317113319">Benzinga Fintech Deal Day &amp; Awards</a> panel was called &#8220;The Evolution of the Retail Investor&#8221; and was hosted by CoinDesk&#8217;s Benjamin Schiller.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42069891/sp-500-to-reach-6500-by-end-of-2025-analysts-predict-could-it-spark-ma-revival">S&amp;P 500 To Reach 6,500 By End Of 2025, Analysts Predict: Could It Spark M&amp;A Revival?</a></li>
</ul>
Photo: Shutterstock.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

EXCLUSIVE: Retail Investors Are Taking On More Risk And Finding Success — Is Crypto Acting As A 'Gateway Trade?'

Cryptocurrency markets are trading higher, with Bitcoin recording a new all-time high at $94,040, according to Coingecko data. 
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$93,312.89</td>
<td>+2.9%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$3,122.39</td>
<td>-0.3%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$243.76</td>
<td>+2.9%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.4053</td>
<td>+10%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00002537&nbsp;&nbsp;</td>
<td>+4%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume increasing by 102.3% and daily active addresses up by 13%. Transactions greater than $100,000 are up from 8,261 to 11,812 in a single day. Exchanges netflows are down by 192%.</li>
<li>Coinglass data reports 98,554 traders were liquidated in the past 24 hours for $289.96 million. Open interest spiked to $59.3 billion.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42059827/crypto-exchange-gemini-launches-services-in-france-following-regulatory-approval">Crypto Exchange Gemini Launches Services In France Following Regulatory Approval</a></li>
<li><a href="https://www.benzinga.com/24/11/42069770/us-congress-could-set-the-stage-for-broader-crypto-adoption-says-digital-asset-leader">Crypto Growth Hinges On &#8216;Thoughtful Policy,&#8217; Clear Regulations, Says Expert</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/42069258/whats-going-on-with-bakkt-holdings-stock-tuesday">What&#8217;s Going On With Bakkt Holdings Stock Tuesday?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42055570/bitfinex-bitcoin-laundering-case-lands-crocodile-of-wall-street-in-jail">Bitfinex Bitcoin Laundering Case Lands &#8216;Crocodile Of Wall Street&#8217; In Jail</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42058823/blackrocks-spot-bitcoin-etf-to-open-for-options-trading-heres-why-it-could-be-a-big-deal-for-bitcoin">BlackRock&#8217;s Spot Bitcoin ETF To Open For Options Trading: Here&#8217;s Why It Could Be A Big Deal For Bitcoin</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bonk (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BONK</a>)</td>
<td>&nbsp;$0.00005573</td>
<td>+14%</td>
</tr>
<tr>
<td>Hedera (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/hbar/usd">HBAR</a>)</td>
<td>&nbsp;$0.1378</td>
<td>+13.5%</td>
</tr>
<tr>
<td>Goatseus Maximus (CRYPTO: GOAT)</td>
<td>&nbsp;$1.17&nbsp;</td>
<td>+12.8%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With Bitcoin prices crossing all-time highs of $94,000, crypto trader Jacob Canfield predicts a minimum target of $97,000.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> &#8211; A breakout fom our ascending triangle above here should give us a minimum target of $97,000. <a href="https://t.co/PLtKTWEmlz">pic.twitter.com/PLtKTWEmlz</a>
&mdash; Jacob Canfield (@JacobCanfield) <a href="https://twitter.com/JacobCanfield/status/1858928153185427592?ref_src=twsrc%5Etfw">November 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader More Crypto Online hopes that Bitcoin can move forward toward $95,000 and then maybe $97,000. On the other hand, the trader <a href="https://x.com/Morecryptoonl/status/1858936812082807069">remains</a> cautious suggesting this could be a corrective range. He believes the structure lacks clear direction and momentum and is therefore very fragile.
Santiment data noted that with Bitcoin peaking to all-time highs, whale transactions and retail FOMO could make the "short-term price action unpredictable, but the long-term indicators for Bitcoin looking quite sound."
It also added that in any long-term bull market, dormant coins continuously moving back into circulation.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f973; Bitcoin has officially made a new all-time high, scraping as high as $93,850 on Coinbase at the time of this writing. Whale transactions and retail FOMO may make the short-term price action unpredictable, but the long-term indicators for BTC (and therefore, crypto) look quite… <a href="https://t.co/Ae5qtdU8QN">pic.twitter.com/Ae5qtdU8QN</a>
&mdash; Santiment (@santimentfeed) <a href="https://twitter.com/santimentfeed/status/1858942762206261428?ref_src=twsrc%5Etfw">November 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/events/24/11/42069387/grant-cardone-calls-himself-a-coward-investor-puts-his-money-in-real-assets">Grant Cardone Calls Himself A &#8216;Coward Investor,&#8217; Puts His Money In &#8216;Real Assets&#8217;</a></li>
</ul>
Image: Shutterstock

$BONK

$ETH

$HBAR

$SHIB

$SOL

Bitcoin Crosses $94,000 For New All-Time High, Dogecoin Back At $0.40, Ethereum Flat: 'Short-Term Price Action Unpredictable,' Say Analysts

Dividends

RGLD

Royal Gold Increases Annual Dividend From $1.60 To $1.80 Per Share

Markets

Interview

Franklin Templeton Research Analyst David Alderman Says There Are A Lot Of Crypto Protocols That Have Been Afraid To Add Some Sort Of Value Accrual Mechanism Or Utility To Token To Avoid Being Labeled As A Security,; Says People Are Hopeful About Where Regulatory Clarity Will Happen, Which Could Drive Growth In The US And Globally

TradeZero CEO And Co-Founder Daniel Pipitone Says [Next Main Street] Expanded Beyond Boarders; Folks Outside Country, Canada, Europe, Asia, Wanting To Trade

S&P Global Ratings Chief DeFi Officer Chuck Mounts Says Thinks First Piece Of Legislation To Get Passed Will Be Stablecoin Legislation

Investors with a lot of money to spend have taken a bullish stance on IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with IONQ, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 62 uncommon options trades for IonQ.
This isn't normal.
The overall sentiment of these big-money traders is split between 58% bullish and 32%, bearish.
Out of all of the special options we uncovered, 14 are puts, for a total amount of $1,331,990, and 48 are calls, for a total amount of $2,500,876.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $7.5 and $40.0 for IonQ, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of IonQ stands at 3648.38, with a total volume reaching 45,328.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in IonQ, situated within the strike price corridor from $7.5 to $40.0, throughout the last 30 days.
<h3>IonQ Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732047353_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>IONQ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$3.8</td>
<td>$3.75</td>
<td>$3.75</td>
<td>$28.00</td>
<td>$467.6K</td>
<td>12</td>
<td>1.8K</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$3.1</td>
<td>$2.95</td>
<td>$2.94</td>
<td>$25.00</td>
<td>$146.5K</td>
<td>3.9K</td>
<td>1.4K</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$3.15</td>
<td>$2.92</td>
<td>$2.91</td>
<td>$25.00</td>
<td>$145.3K</td>
<td>3.9K</td>
<td>1.9K</td>
</tr>
<tr>
<td>IONQ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$11.0</td>
<td>$10.95</td>
<td>$10.95</td>
<td>$35.00</td>
<td>$141.2K</td>
<td>1.2K</td>
<td>151</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$13.25</td>
<td>$13.05</td>
<td>$13.1</td>
<td>$15.00</td>
<td>$131.0K</td>
<td>7.6K</td>
<td>151</td>
</tr>
</tbody>
</table>

<h3>About IonQ</h3>
IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems, and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.
Following our analysis of the options activities associated with IonQ, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of IonQ</h3>
<ul>
<li>Currently trading with a volume of 25,367,717, the IONQ's price is up by 10.7%, now at $27.93. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 99 days.</li>
</ul>
<h3>Professional Analyst Ratings for IonQ</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $20.666666666666668.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Needham continues to hold a Buy rating for IonQ, targeting a price of $18. 
&#x2A; Maintaining their stance, an analyst from Benchmark continues to hold a Buy rating for IonQ, targeting a price of $22. 
&#x2A; Consistent in their evaluation, an analyst from Craig-Hallum keeps a Buy rating on IonQ with a target price of $22. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest IonQ options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

IONQ

Market Whales and Their Recent Bets on IONQ Options

Deep-pocketed investors have adopted a bullish approach towards Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CMG usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Chipotle Mexican Grill. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 76% leaning bullish and 15% bearish. Among these notable options, 2 are puts, totaling $346,912, and 11 are calls, amounting to $1,090,010.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $46.0 and $72.0 for Chipotle Mexican Grill, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Chipotle Mexican Grill stands at 905.88, with a total volume reaching 9,383.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Chipotle Mexican Grill, situated within the strike price corridor from $46.0 to $72.0, throughout the last 30 days.
<h3>Chipotle Mexican Grill Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732047347_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$17.4</td>
<td>$16.7</td>
<td>$17.4</td>
<td>$46.00</td>
<td>$631.6K</td>
<td align="right">970</td>
<td align="right">706</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$14.6</td>
<td>$14.3</td>
<td>$14.3</td>
<td>$72.00</td>
<td>$318.9K</td>
<td align="right">57</td>
<td align="right">224</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$17.5</td>
<td>$16.7</td>
<td>$17.4</td>
<td>$46.00</td>
<td>$83.5K</td>
<td align="right">970</td>
<td align="right">772</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$13.3</td>
<td>$12.8</td>
<td>$12.8</td>
<td>$60.00</td>
<td>$64.0K</td>
<td align="right">500</td>
<td align="right">11</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$15.6</td>
<td>$15.2</td>
<td>$15.42</td>
<td>$55.00</td>
<td>$61.6K</td>
<td align="right">127</td>
<td align="right">62</td>
</tr>
</tbody>
</table>

<h3>About Chipotle Mexican Grill</h3>
Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $9.9 billion in 2023. The Mexican concept is almost exclusively company-owned, with just two license stores opearted through a master franchise relationship with Alshaya Group in the Middle East. It had a footprint of nearly 3,440 stores at the end of 2023, heavily indexed to the United States, although it maintains a small presence in Canada, the UK, France, and Germany. Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
Having examined the options trading patterns of Chipotle Mexican Grill, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Chipotle Mexican Grill Standing Right Now?</h3>
<ul>
<li>With a trading volume of 6,291,565, the price of CMG is down by -0.07%, reaching $58.77.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 77 days from now.</li>
</ul>
<h3>What The Experts Say On Chipotle Mexican Grill</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $63.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from BMO Capital persists with their Market Perform rating on Chipotle Mexican Grill, maintaining a target price of $56. 
&#x2A; An analyst from Stephens &amp; Co. persists with their Equal-Weight rating on Chipotle Mexican Grill, maintaining a target price of $65. 
&#x2A; An analyst from RBC Capital has revised its rating downward to Outperform, adjusting the price target to $70. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Chipotle Mexican Grill with a target price of $67. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Chipotle Mexican Grill, targeting a price of $60. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Chipotle Mexican Grill options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Chipotle Mexican Grill's Options: A Look at What the Big Money is Thinking

Whales with a lot of money to spend have taken a noticeably bearish stance on Moderna.
Looking at options history for Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) we detected 37 trades.
If we consider the specifics of each trade, it is accurate to state that 32% of the investors opened trades with bullish expectations and 59% with bearish.
From the overall spotted trades, 19 are puts, for a total amount of $1,152,330 and 18, calls, for a total amount of $1,026,287.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $300.0 for Moderna over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Moderna's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Moderna's significant trades, within a strike price range of $30.0 to $300.0, over the past month.
<h3>Moderna Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732047342_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$3.5</td>
<td>$3.35</td>
<td>$3.35</td>
<td>$40.00</td>
<td>$169.5K</td>
<td>1.3K</td>
<td>1.0K</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$34.95</td>
<td>$33.8</td>
<td>$33.8</td>
<td>$70.00</td>
<td>$168.9K</td>
<td>1.0K</td>
<td>50</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$24.05</td>
<td>$24.0</td>
<td>$24.05</td>
<td>$60.00</td>
<td>$137.0K</td>
<td>1.1K</td>
<td>59</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$6.3</td>
<td>$6.2</td>
<td>$6.21</td>
<td>$45.00</td>
<td>$124.0K</td>
<td>733</td>
<td>389</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$3.35</td>
<td>$3.3</td>
<td>$3.3</td>
<td>$40.00</td>
<td>$113.1K</td>
<td>1.3K</td>
<td>344</td>
</tr>
</tbody>
</table>

<h3>About Moderna</h3>
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Having examined the options trading patterns of Moderna, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Moderna</h3>
<ul>
<li>Trading volume stands at 5,807,278, with MRNA's price down by -4.83%, positioned at $37.6.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 93 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

MRNA

Unpacking the Latest Options Trading Trends in Moderna

GTN CEO, Americas Eric Krueger Says To Gain Share And Stand Out In Crowded And Competitive Market, It Has To Be About Product Innovation

DTCC Digital Assets Executive Director Jennifer O'Rourke Says It Has Been Explicitly Clear That There Is An Attitude To Increase Velocity Along The Deployment And Utilization Of Tokenized Assets

GTN CEO, Americas Eric Krueger Says It Is About Taking Existing Products And Making Legacy Products More Easy To Understand And Digest For End Retail Client

Alpaca Co-Founder & CEO Yoshi Yokokawa In Response To Public.com Spokesperson Says That Is What We Thought At Lehman Brothers

Public.com Spokesperson Says Triple B Bonds Are Still Pretty Safe

TradeZero CEO And Co-Founder Daniel Pipitone Says Futures For Us Is Next Natural Progression; People Can Participate In Meaningful Way In Mini-Micro Products On Future Side

Public.com Spokesperson Says Access To Huge Part Of Market Is Missed For A Lot Of Folks; We're Early Stage Of Fixed Income

Alpaca Co-Founder & CEO Yoshi Yokokawa Says I Think It Comes Down To Cost; To Make Mainstreet Customers Make Sense; Need To Have Operating Costs To Be Super Super Low; Wallet Size [Globally] Are Super Small; Our Job Is To Be An Infrastructure; Make Sure Each Component Of These Details Are Flexible

UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shares have declined 5.3% over the past week as the company faces a significant legal challenge to its <a href="https://www.benzinga.com/news/legal/24/11/41917050/justice-department-moves-to-block-unitedhealths-amedisys-takeover-whats-going-on">$3.3 billion acquisition</a> of Amedisys Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMED#NASDAQ">AMED</a>).
What To Know: The U.S. Justice Department, along with attorneys general from multiple states, has recently filed a lawsuit to block the deal, citing antitrust concerns in the home health services sector. 
The agency argues the merger could lead to higher healthcare costs, particularly as Amedisys is a direct competitor to UnitedHealth&#8217;s LHC Group, which was acquired for $5.4 billion in 2022.
The Justice Department contends that allowing the merger would tighten UnitedHealth&#8217;s control over the home health and hospice care market, potentially disadvantaging seniors and caregivers. 
In response, UnitedHealth and Amedisys have proposed selling assets to VitalCaring Group to address these concerns, but negotiations have yet to alleviate regulatory resistance.
UnitedHealth's Optum unit has actively <a href="https://www.benzinga.com/general/health-care/24/11/41987383/unitedhealths-optum-defends-multi-billion-dollar-amedisys-deal-ensures-competitive-landscape">defended the merger</a>, emphasizing the fragmented nature of the home healthcare industry and its potential to address the growing demand for elder care as the U.S. population ages. However, skepticism persists as analysts and regulators scrutinize the impact on market competition.
Read Also: <a href="https://www.benzinga.com/news/events/24/11/42069387/grant-cardone-calls-himself-a-coward-investor-puts-his-money-in-real-assets">Grant Cardone Calls Himself A &#8216;Coward Investor,&#8217; Puts His Money In &#8216;Real Assets&#8217;</a>
<h2 class="wp-block-heading">How To Buy UNH Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in UnitedHealth Group&#8217;s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, UNH has a 52-week high of $630.73 and a 52-week low of $436.38.

AMED

What's Going On With UnitedHealth Stock?

Enka Insaat Ve Sanayi

Comments

Enka Insaat Ve Sanayi

Actualités

Dernières nouvelles pour Enka Insaat Ve Sanayi (OTC:EKIVF) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL